Alberto Ramos, MD
Sleep Medicine · Miami, FLNPI 1215149265
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,876 of the $8,424 with a category attached, or 81.6%. 11 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 52.5% of the total. Reporting peaked in 2024 at $4,583 and has fallen 94.1% since, to $271 in 2025.
Across 45 payments — averaging $187.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$4K
- ZOLL Respicardia, Inc.$2K
- Biogen$800
- Harmony Biosciences LLC$480
- Resmed Corp$239
- Axsome Therapeutics, Inc.$157
- plus $327 from 5 others
Across 1 payment — averaging $120,408 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$120K
What the payments were for
- Consulting fees$6,87682%
- Food & beverage$1,28815%
- Education$2613%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 14 | $4,421 |
| ZOLL Respicardia, Inc. | 2 | $2,000 |
| Biogen | 1 | $800 |
| Harmony Biosciences LLC | 10 | $480 |
| Resmed Corp | 4 | $239 |
| Axsome Therapeutics, Inc. | 4 | $157 |
| Abbott | 2 | $150 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $107 |
| Idorsia Pharmaceuticals US Inc | 2 | $37 |
| Boehringer Ingelheim | 1 | $18 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XYWAV$4,076
- remede System$2,000
- Epic$103
How this compares
$8,424 in reported general payments places this provider in the 75th percentile of 77 sleep medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelsomraSuvorexant | 14 | $6,280 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 14 | $603 |
| Zolpidem Tartrate | 27 | $190 |
| Gabapentin | 24 | $133 |
| Eszopiclone | 14 | $129 |
| Clonazepam | 12 | $72 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Miami
- Edward MezerhaneMiami$537K
- Sergio JaramilloMiami$32K
- Carlos Ramirez MejiaMiami$25K
- Harneet WaliaMiami$19K
- Rosa GarciaMiami$3K
- Ghaith ShukriMiami$2K
- Salim DibMiami$2K
- Dionne MorganMiami$797
- Jeremy McConnellBradenton$615K
- Shane DrahosWinter Garden$317K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.